3.050USD-14.57%Mkt Cap: 9.21M $P/E: —1d ago
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratub…
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap9.21M $
Enterprise Value8.55M $
Revenue (TTM)2.38M $
Gross Profit1.42M $
Net Income (TTM)-18.63M $
Revenue/Share0.9520 USD
Last Price3.050 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees51
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.53
PEG—
EV/EBITDA-0.53
EV/Revenue3.60
P/S3.87
P/B1.26
EPS (TTM)-4.80
EPS (Forward)-5.80
52W Range
0.285446% of range6.285
52W High6.285 USD
52W Low0.2854 USD
Profitability
Gross Margin61.96%
Oper. Margin-994.03%
EBITDA Margin0.00%
Profit Margin-812.27%
ROE-317.38%
ROA-89.88%
Growth
Revenue Growth24.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.69M $
CapEx (TTM)630.10K $
FCF Margin-494.79%
FCF Yield-127.70%
Net Debt-658.04K $
Net Debt/EBITDA0.04
Balance Sheet
Debt/Equity0.80
Current Ratio3.91
Quick Ratio1.76
Book Value/Sh2.414 USD
Cash/Share1.784 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 8, 2026
Analyst Consensus
Rating—
Target (Mean)63.33 USD
Upside (mean)+1976.5%
Target Range30.00 USD – 130.00 USD
$30.00+1976.5% to mean$130.00
# Analysts—
Ownership
Shares Out.3.02M
Float2.50M
Insiders9.40%
Institutions10.08%
Short Interest
Short Ratio3.1d
Short % Float6.60%
Short % Out.6.30%
Shares Short190.23K
Short (prev mo.)166.32K
Technical
SMA 505.802 (-47.4%)
SMA 20010.69 (-71.5%)
Beta-2.13
S&P 52W Chg20.25%
Avg Vol (30d)201.54K
Avg Vol (10d)30.96K
Technical Indicators
RSI (14)45.0
MACD0.2679
MACD Signal0.4789
MACD Hist.-0.2110
BB Upper4.473 USD
BB Middle3.857 USD
BB Lower3.242 USD
BB Width31.90%
ATR (14)0.4069 USD
Vol Ratio (20d)1.07x